Noticias de ISRG_US
Noticias del mercado
Últimas noticias sobre ISRG_US — 632 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
At the close on September 4, 2026, Intuitive Surgical stock finished at USD 366.70 on the Nasdaq, do
Intuitive Surgical stock is trading well below its 52-week high, even after a strong Q2 2026 with do
Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried inside their business models quietly separates a compounder from a cyclical recovery story.
Intuitive Surgical stock is trading firmly ahead of its Q2 2026 earnings release, with investors wat
Intuitive Surgical stock steadies after Q2 2026 revenue of USD 2.89 billion and EPS of USD 2.80. The
Intuitive Surgical (ISRG) Q4 2025 earnings: EPS beat estimates at $2.53 vs. $2.27 expected. View earnings history, market reaction, and analysis from 24/7 Wall St.
Intuitive Surgical (ISRG) Q2 2025 earnings: EPS beat estimates at $2.19 vs. $1.93 expected. View earnings history, market reaction, and analysis from 24/7 Wall St.
Intuitive Surgical has notably underperformed the Health Care Equipment industry over the past year, but analysts are highly optimistic about the stock’s prospects.
Intuitive Surgical stock is holding in the low $370s, far under its 52-week peak, while strong Q2 20
Compare SS Innovations vs. Intuitive Surgical in medical robotics—why SS Innovations may offer asymmetric upside, stronger growth, and better returns. Click to read.
Intuitive Surgical stock trades at $372.60 on Nasdaq as of August 30, 2026, while growing use of its
Intuitive Surgical is a biotechnology company developing tools for minimally invasive, robotics-assisted surgeries. It joined the Fortune 500 list for the first time in 2024. Five years after its 1995 founding, Intuitive introduced its da Vinci robot, a system using a 3D endoscopic camera and small arms operated by a surgeon at a console. According to the company, the da Vinci model has been used in 14 million procedures, including tonsillectomies and hysterectomies. Its da Vinci 5 model gained FDA approval in March 2024.
Página 1 de 32